New combo vaccine targets two respiratory viruses in seniors

NCT ID NCT06134648

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new vaccine designed to protect against two respiratory viruses: RSV and hMPV. It involved 646 healthy adults aged 60 and older who received either the vaccine or a placebo. The goal was to see if the vaccine is safe and triggers a strong immune response, with some participants getting a booster shot after 12 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AMR Chicago, Oakbrook Terrace Site Number : 8400019

    Oakbrook Terrace, Illinois, 60181, United States

  • AMR Kansas City Site Number : 8400014

    Kansas City, Missouri, 64114, United States

  • AMR Knoxville Site Number : 8400010

    Knoxville, Tennessee, 37919, United States

  • AMR Lexington Site Number : 8400008

    Lexington, Kentucky, 40509, United States

  • Collaborative Neuroscience Research Site Number : 8400017

    Los Alamitos, California, 90720, United States

  • DM Clinical Research - Tomball Site Number : 8400004

    Tomball, Texas, 77375, United States

  • Investigational Site Number : 6300001

    San Juan, 00909, Puerto Rico

  • Investigational Site Number : 6300002

    Guayama, 000784, Puerto Rico

  • Investigational Site Number : 6300003

    San Juan, 00918, Puerto Rico

  • Matrix Clinical Research Site Number : 8400011

    Los Angeles, California, 90057, United States

  • Peninsula Research Associates Site Number : 8400001

    Rolling Hills Estates, California, 90274, United States

  • Suncoast Research Associates, LLC Site Number : 8400002

    Miami, Florida, 33173, United States

  • Velocity Clinical Research, Sioux City Site Number : 8400012

    Sioux City, Iowa, 51106, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.